- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 231/40 - Acylated on said nitrogen atom
Patent holdings for IPC class C07D 231/40
Total number of patents in this class: 413
10-year publication summary
|
44
|
46
|
24
|
45
|
26
|
25
|
27
|
19
|
17
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 3042 |
24 |
| Bayer Cropscience AG | 2241 |
15 |
| Array BioPharma Inc. | 551 |
12 |
| BASF SE | 19740 |
10 |
| Novartis AG | 11238 |
8 |
| The Regents of the University of California | 18943 |
8 |
| Dow AgroSciences LLC | 1267 |
8 |
| Boehringer Ingelheim International GmbH | 4629 |
7 |
| Shionogi & Co., Ltd. | 914 |
7 |
| F. Hoffmann-La Roche AG | 7958 |
6 |
| AstraZeneca UK Limited | 768 |
6 |
| Aurigene Discovery Technologies Limited | 120 |
6 |
| Theravance Biopharma R&D IP, LLC | 550 |
6 |
| Lead Pharma Holding B.V. | 27 |
6 |
| Sanofi | 3836 |
6 |
| Corteva Agriscience LLC | 2494 |
6 |
| Araxes Pharma LLC | 91 |
5 |
| Medivir UK Ltd | 7 |
5 |
| Plexxikon Inc. | 168 |
5 |
| Idorsia Pharmaceuticals Ltd. | 385 |
5 |
| Other owners | 252 |